Guardian Pharmacy Services (NYSE:GRDN) Trading Up 4.6% – Here’s What Happened

Guardian Pharmacy Services, Inc. (NYSE:GRDN) shares shot up 4.6% on Monday . The stock traded as high as $22.43 and last traded at $22.39. 37,424 shares changed hands during trading, a decline of 80% from the average session volume of 188,664 shares. The stock had previously closed at $21.41.

Wall Street Analyst Weigh In

GRDN has been the subject of a number of analyst reports. Truist Financial lifted their target price on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Stephens began coverage on Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price target for the company. Finally, Raymond James initiated coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective on the stock.

Guardian Pharmacy Services Stock Performance

The stock’s 50 day simple moving average is $21.19.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. Equities research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Insider Transactions at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Steven D. Cosler acquired 7,000 shares of Guardian Pharmacy Services stock in a transaction dated Tuesday, November 19th. The stock was bought at an average cost of $21.22 per share, with a total value of $148,540.00. Following the acquisition, the director now owns 17,713 shares of the company’s stock, valued at approximately $375,869.86. The trade was a 65.34 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas J. Salentine, Jr. bought 35,714 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was acquired at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the purchase, the director now owns 35,714 shares of the company’s stock, valued at $499,996. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here.

Institutional Investors Weigh In On Guardian Pharmacy Services

Large investors have recently modified their holdings of the stock. Stephens Inc. AR acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth approximately $189,000. Virtu Financial LLC bought a new stake in Guardian Pharmacy Services during the 3rd quarter worth approximately $279,000. Barclays PLC acquired a new stake in Guardian Pharmacy Services during the 3rd quarter valued at $311,000. Point72 DIFC Ltd bought a new position in Guardian Pharmacy Services in the 3rd quarter valued at $573,000. Finally, Royce & Associates LP acquired a new position in Guardian Pharmacy Services in the third quarter worth $1,260,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.